Around 1990, psychologists and educators began to notice increasing us
e of methylphenidate by students. Diagnosis of attention-deficit/hyper
activity disorder by family physicians and pediatricians was most comm
only based on brief behavioral descriptions by parents and, infrequent
ly, by use of rating scales. At that time, the present researchers beg
an to explore the development of a school-based, methodologically soun
d, and inexpensive method of assessing the efficacy of stimulant medic
ations, which would ensure reasonable compliance by teachers, parents,
and students in monitoring the effects of medications and placebos. T
his article focuses on the methodological issues involved in choosing
instruments to monitor behavior, once a comprehensive evaluation has s
uggested trials on Ritalin. Case examples illustrate problems of teach
er compliance in filling out measures, supplying adequate placebos, an
d obtaining physician cooperation, and with the practical issue of pro
viding adequate data without overwhelming the time and resources of pa
rticipants. Emerging school-based methodologies are discussed with rec
ommendations for future efforts.